Benjamin Kaffenberger, MD, MS, FAAD
SESSIONS
F070 The Morbilliform Eruption: Differentiation and Treatment of Viral, Low-risk Drug, Severe Cutaneous Adverse Reactions, and GVHD
Mar 9, 2025
•
3:30 PM - 5:30 PM
•
W204C
HANDOUTS
Login to view handouts
DISCLOSURES
Almirall – Consultant (1099 relationship)(Honoraria); Biogen – Investigator(Grants/Research Funding); Boehringer Ingelheim – Investigator(Grants/Research Funding), Speaker(Fees); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Dermatology Foundation – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant (1099 relationship)(Honoraria); HCW Biologics – Investigator(Grants/Research Funding); InflaRx – Investigator(Grants/Research Funding); Merck – Investigator(Grants/Research Funding); National Comprehensive Cancer Network – Speaker(Honoraria); National Psoriasis Foundation – Investigator(Grants/Research Funding);